Chhaya Aggarwal
Westchester Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chhaya Aggarwal.
Cardiology in Review | 2015
Alan Gass; Abbas Emaminia; Gregg Lanier; Chhaya Aggarwal; Kathy A. Brown; Maureen Raffa; Masashi Kai; David Spielvogel; Ramin Malekan; Gilbert H.L. Tang; Steven L. Lansman
The prevalence of heart failure continues to rise due to the aging population and longer survival of people with conditions that lead to heart failure, eg, hypertension, diabetes, and coronary artery disease. Although medical therapy has had an important impact on survival of patients and improving quality of life, heart transplantation remains the definitive therapy for patients that eventually deteriorate. Since the first successful heart transplantation in 1967, significant improvements have been made regarding donor and recipient selection, surgical techniques, and postoperative care. However, the number of potential organ donors has not changed and the growing number of patients in need for transplantation has resulted an increase in waiting list time, and the need for mechanical support. To overcome this issue, the United Network for Organ Sharing implemented an allocation system to prioritize the sickest patients on the list to receive organs. Despite the careful selection of patients, pretransplant immunological screening, and multidrug immunosuppressive regimens, acute and chronic rejections occur and potentially limit graft and patient survival. Treatment for rejection largely depends on the type of rejection, the presence of hemodynamic compromise, and time after transplantation. The limiting factor for long-term graft survival is allograft vasculopathy, an immune-mediated process causing diffuse narrowing of the coronary arteries. Percutaneous coronary intervention and coronary artery bypass surgery are often not an option for this vasculopathy due to the lack of focal lesions, and retransplantation is the only option in appropriate patients.
Coronary Artery Disease | 2011
Chhaya Aggarwal; Julio A. Panza; Howard A. Cooper
ObjectivesRed blood cell (RBC) transfusions are common among patients with acute coronary syndromes (ACS). We sought to determine their impact on mortality according to indication. MethodsWe conducted a case–control analysis of ACS patients admitted to a single coronary care unit. Transfused patients were matched to nontransfused patients for age, estimated glomerular filtration rate, and nadir hematocrit. Conditional logistic regression analysis was used to determine the independent relationship between RBC transfusion and inhospital mortality. Results were stratified according to the indication for transfusion. ResultsOf the 3190 patients admitted with ACS, 206 (6.4%) received at least one RBC transfusion. Of these, 103 patients were matched to 185 nontransfused patients. The most common indications for transfusion were nonspecific anemia (48%) and overt blood loss (42%). Transfused patients had a significantly lower ejection fraction and were more likely to present in Killip class IV, undergo pulmonary artery catheterization, and require an intra-aortic balloon pump. On univariate analysis, RBC transfusion was associated with a doubling of the risk of inhospital mortality [odds ratio: 2.0; 95% confidence interval: 1.0–3.9; P=0.046]. However, after adjustment for confounders, transfusion was no longer significantly associated with higher inhospital mortality (odds ratio: 1.8; 95% confidence interval: 0.6–5.1; P=0.3). On stratified analysis, RBC transfusion was not significantly associated with inhospital mortality among patients transfused for either nonspecific anemia or overt blood loss. ConclusionsAmong coronary care unit patients with ACS, RBC transfusion does not seem to have a significant impact on inhospital mortality irrespective of the indication for transfusion.
Journal of the American College of Cardiology | 2017
Srikanth Yandrapalli; Sohaib Tariq; Venkat Lakshmi Kishan Vuddanda; Prakash Harikrishnan; Viswajit Reddy Anugu; Zeeshan Solangi; Wilbert S. Aronow; Sachin Sule; Alan Gass; Chhaya Aggarwal; William H. Frishman; Gregg Fonarow; Ali Ahmed; Jason Jacobson; Sei Iwai; Howard A. Cooper; Julio A. Panza; Gregg Lanier
Background: Abnormal anatomy, sympathetic denervation, rejection, and infection may increase the risk for arrhythmias in heart transplant (HT) recipients. Data are limited regarding arrhythmias in hospitalized HT patients. Methods: Using the U. S. Nationwide Inpatient Sample databases 2003 through
Journal of the American College of Cardiology | 2018
Srikanth Yandrapalli; Yogita Rochlani; Prakash Harikrishnan; Venkat Lakshmi Kishan Vuddanda; Sisir Siddamsetti; Wilbert S. Aronow; Chhaya Aggarwal; William H. Frishman; Gregg Lanier; Alan Gass; Howard A. Cooper; Julio A. Panza
Journal of the American College of Cardiology | 2018
Luis Francisco; Hidalgo Ponce; Tasleem Katchi; Chhaya Aggarwal; Wilbert S. Aronow
Journal of the American College of Cardiology | 2017
Srikanth Yandrapalli; Sohaib Tariq; Prakash Harikrishnan; Venkat Lakshmi Kishan Vuddanda; Abdallah Sanaani; Wilbert S. Aronow; Sachin Sule; Alan Gass; Chhaya Aggarwal; William H. Frishman; Gregg Fonarow; Ali Ahmed; Gregg Lanier; Howard A. Cooper; Julio A. Panza
Journal of Cardiac Failure | 2017
Tasleem Katchi; Carolina Ponce Orellana; Chhaya Aggarwal; Gregg Lanier; Alan Gass
Journal of Cardiac Failure | 2017
Amanda Lloji; Tonusri Nag; Pratik Mondal; Srikanth Yandrapalli; Chhaya Aggarwal; Howard A. Cooper; Gregg Lanier; Julio A. Panza; Alan Gass
Journal of Cardiac Failure | 2017
Zeeshan Solangi; Ahda Noor; Syed Zaid; Arun Kumar; Tasleem Katchi; Srikanth Yandrapalli; Saikrishna Patiballa; Chhaya Aggarwal; Sachin Sule; Julio A. Panza; Howard A. Cooper; Gregg Lanier
Journal of Cardiac Failure | 2017
Tasleem Katchi; Chhaya Aggarwal; John T. Fallon; Howard A. Cooper; Julio A. Panza; Alan Gass; Gregg Lanier